SLC22A8 and nonpapillary renal cell carcinoma: We collected 539 primary ccRCC cases with clinical and gene expression data from TCGA database and divided ccRCC patients into a low expression group (n = 269) and a high expression group (n = 270) based on the mean SLC22A8 relative expression.